Cleared Traditional

K860570 - ANGIO-FLO CONTINUOUS ARTERIAL CATH FLUSH DEVICE

K860570 is an FDA 510(k) clearance for ANGIO-FLO CONTINUOUS ARTERIAL CATH FLUS..., manufactured by Parke-Davis Co.. The device is a Class 2 Cardiovascular device with product code KRA cleared through the Traditional 510(k) pathway after a 45-day FDA review.

K860570 · Parke-Davis Co. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1986
Decision
45d
Days
Class 2
Risk

K860570 is an FDA 510(k) clearance for the ANGIO-FLO CONTINUOUS ARTERIAL CATH FLUSH DEVICE. Classified as Catheter, Continuous Flush (product code KRA), Class II - Special Controls.

Submitted by Parke-Davis Co. (Rochester, US). The FDA issued a Cleared decision on March 31, 1986 after a review of 45 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1210 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Parke-Davis Co. devices

FDA 510(k) Submission Details - K860570

510(k) Number K860570 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 14, 1986
Decision Date March 31, 1986
Days to Decision 45 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
80d faster than avg
Panel avg: 125d · This submission: 45d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KRA Device Classification - Class 2, Special Controls

Product Code KRA Catheter, Continuous Flush
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1210
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - KRA Catheter, Continuous Flush

All 136
Devices cleared under the same product code (KRA) and FDA review panel - the closest regulatory comparables to K860570.
VAMP VENOUS/ARTERIAL BLOOD MANAGEMENT PROTECTION
K885281 · Baxter Healthcare Corp · Mar 1989
JEHLE CORONARY PERFUSION CATHETERS
K884946 · Pilling Co. · Feb 1989
JEHLE CORONARY PERFUSION CATHETERS
K874242 · Pilling Co. · Dec 1987
ANGIO-FLO CONTIN-ARTERIAL FLUSH DEV.
K832058 · Parke-Davis Co. · Sep 1983
CONTINUOUS FLUSH DEVICE
K831730 · American Pharmaseal Div. Ahsc · Jul 1983
FLUSHFLO II
K812173 · Bentley Laboratories, Inc. · Aug 1981